Results 221 to 230 of about 198,756 (335)

Granuloma annulare: not as simple as it seems. [PDF]

, 2010
Parish, Lawrence Charles, Witkowski, Joseph A.   +1 more
core   +1 more source

Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma.

Blood, 2015
M. Duvic, L. Pinter-Brown, F. Foss, L. Sokol, J. Jorgensen, Pramoda Challagundla, K. Dwyer, Xiaoping Zhang, M. Kurman, R. Ballerini, Li Liu, Youn H. Kim   +11 more
semanticscholar   +1 more source

Dasatinib Produces Lengthy Remissions of Extramedullary Leukemia: A Retrospective Observational Study

European Journal of Haematology, Volume 116, Issue 3, Page 302-310, March 2026.
ABSTRACT Since 2004, patients receiving imatinib with relapse in non‐marrow sites were given dasatinib to preserve control of leukemic marrow. Remissions in CNS and other organs began to be reported and are continuously observed to present. With resistance to one BCR::ABL1 tyrosine kinase inhibitor and sensitivity to a dual BCR::ABL1/SRC inhibitor ...
I. Cunningham, R. A. Fisher, J. Yang, Y. Guo, U. Bommhardt   +4 more
wiley   +1 more source

A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T‐cell lymphoma

British Journal of Haematology, 2015
F. Foss, R. Advani, M. Duvic, K. Hymes, T. Intragumtornchai, A. Lekhakula, O. Shpilberg, A. Lerner, R. Belt, E. Jacobsen, G. Laurent, D. Ben-yehuda, M. Beylot‐Barry, U. Hillen, P. Knoblauch, G. Bhat, S. Chawla, L. F. Allen, B. Pohlman   +18 more
semanticscholar   +1 more source

Restricted Expression of the Constant Region 1 of T‐Cell Receptor β by Flow Cytometry Facilitates Detection of T‐Cell Neoplasms With High Specificity but Moderate Predictive Value

European Journal of Haematology, Volume 116, Issue 3, Page 245-255, March 2026.
ABSTRACT Objectives To determine the diagnostic value of disclosing monotypic T‐cell populations by expression analysis of the constant region 1 of T‐cell receptor β (TRBC1) by flow cytometry, for the detection of T‐cell neoplasms, in a routine hematopathology practice setting.
Nilofar Rajabian, Olof Axler, Erik Wistén, Anna Porwit, Mats Ehinger   +4 more
wiley   +1 more source

Increased Risk of Hematologic Malignancy in Moderate to Severe Psoriasis in Relation to the Use of Systemic Immunosuppressants: A Nationwide Population-Based Matched Cohort Study. [PDF]

J Korean Med Sci
Woo YR, Chae K, Song S, Lee S, Lee YJ, Kang H, Kim S, Kim JE.   +7 more
europepmc   +1 more source

Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma.

Blood, 2015
A. Rook, J. Gelfand, M. Wysocka, A. Troxel, B. Benoit, C. Surber, R. Elenitsas, M. Buchanan, Deborah Leahy, R. Watanabe, I. Kirsch, Ellen J. Kim, R. Clark   +12 more
semanticscholar   +1 more source

Evaluating VEGFR2 as a Target for Anti‐Tumour Therapy in Canine Melanoma

Veterinary and Comparative Oncology, Volume 24, Issue 1, Page 95-104, March 2026.
ABSTRACT Vascular endothelial growth factor receptor 2 (VEGFR2) is a key target for anti‐angiogenic oncotherapy, as inhibiting this receptor on tumour vasculature slows tumour development and enhances drug‐ and immune infiltration, improving therapy outcome.
Esther Hindriks, Wilhelmina Bergmann, Aitor Martínez Ruiz, Maurice M. J. M. Zandvliet, Alice J. A. M. Sijts, Femke Broere   +5 more
wiley   +1 more source

Unusual Presentation of Subcutaneous Panniculitis-Like T-Cell Lymphoma. [PDF]

Clin Case Rep
Alkallabi M, Alotaibi H, Nagshabandi KN, Bin Idris R, Abualola AH, Alshehri NA, Alhumidi A.   +6 more
europepmc   +1 more source

Detection of residual host cells after bone marrow transplantation using non-isotopic in situ hybridization [PDF]

, 1993
Cremer, Thomas, Knuutila, Sakari, Popp, Susanne, Ruutu, Tapani, Volin, L., Wessman, M.   +5 more
core